Dr. Oliver Grunman

Yeah, so it's interesting that we have this discussion today because just the other day, yesterday, literally, I was giving a presentation at the North American Congress on Clinical Toxicology on Kratom together with a few other folks. And we are not yet sure how somebody can get to very high concentrations in their blood of mitragynine that would cause or would contribute to a fatality.

Yeah, so it's interesting that we have this discussion today because just the other day, yesterday, literally, I was giving a presentation at the North American Congress on Clinical Toxicology on Kratom together with a few other folks. And we are not yet sure how somebody can get to very high concentrations in their blood of mitragynine that would cause or would contribute to a fatality.

Yeah, so it's interesting that we have this discussion today because just the other day, yesterday, literally, I was giving a presentation at the North American Congress on Clinical Toxicology on Kratom together with a few other folks. And we are not yet sure how somebody can get to very high concentrations in their blood of mitragynine that would cause or would contribute to a fatality.

With this evolution of the kratom market where we see extracts, concentrates, isolates emerging, that might be a driving force behind these lethal outcomes, which we have not seen in Southeast Asia with just chewing on the leaf or making that tea. So it's clear there's a strong suspicion that these high potency extracts and isolates are driving the lethality.

With this evolution of the kratom market where we see extracts, concentrates, isolates emerging, that might be a driving force behind these lethal outcomes, which we have not seen in Southeast Asia with just chewing on the leaf or making that tea. So it's clear there's a strong suspicion that these high potency extracts and isolates are driving the lethality.

With this evolution of the kratom market where we see extracts, concentrates, isolates emerging, that might be a driving force behind these lethal outcomes, which we have not seen in Southeast Asia with just chewing on the leaf or making that tea. So it's clear there's a strong suspicion that these high potency extracts and isolates are driving the lethality.

Yeah. I actually think that what is happening now in the crypto market is exactly mirroring what is happening with cannabis, right? When we look at A decade ago, we had THC concentrations that ranged from like maybe 5 to 12 percent, maybe 15 percent in high quality cannabis products. And now we have concentrates or edibles that contain 40 percent THC.

Yeah. I actually think that what is happening now in the crypto market is exactly mirroring what is happening with cannabis, right? When we look at A decade ago, we had THC concentrations that ranged from like maybe 5 to 12 percent, maybe 15 percent in high quality cannabis products. And now we have concentrates or edibles that contain 40 percent THC.

Yeah. I actually think that what is happening now in the crypto market is exactly mirroring what is happening with cannabis, right? When we look at A decade ago, we had THC concentrations that ranged from like maybe 5 to 12 percent, maybe 15 percent in high quality cannabis products. And now we have concentrates or edibles that contain 40 percent THC.

So very different ballgame, very different amount that you can get into your body from sometimes ingesting much smaller amounts.

So very different ballgame, very different amount that you can get into your body from sometimes ingesting much smaller amounts.

So very different ballgame, very different amount that you can get into your body from sometimes ingesting much smaller amounts.

Yeah. So I like the way you phrased that because it wouldn't fit in the current regulatory scheme or how this would ever be realized.

Yeah. So I like the way you phrased that because it wouldn't fit in the current regulatory scheme or how this would ever be realized.

Yeah. So I like the way you phrased that because it wouldn't fit in the current regulatory scheme or how this would ever be realized.

But if you look, for example, at some of the ephedrine, pseudoephedrine products that were kind of pulled from the market in regards to just being over the counter, so you could just buy them from a pharmacy without any questions being asked, because we know that pseudoephedrine, ephedrine and the like products are being used in the manufacture of methamphetamine.

But if you look, for example, at some of the ephedrine, pseudoephedrine products that were kind of pulled from the market in regards to just being over the counter, so you could just buy them from a pharmacy without any questions being asked, because we know that pseudoephedrine, ephedrine and the like products are being used in the manufacture of methamphetamine.

But if you look, for example, at some of the ephedrine, pseudoephedrine products that were kind of pulled from the market in regards to just being over the counter, so you could just buy them from a pharmacy without any questions being asked, because we know that pseudoephedrine, ephedrine and the like products are being used in the manufacture of methamphetamine.

And instead, they're now behind the counter and you can get a certain amount without requiring a prescription, but you still need to present some form of identification that has been done in all US states by now. So I think that Kratom and or Tianeptin would qualify for something like that because then you need to interact with a pharmacist or a pharmacy technician to

And instead, they're now behind the counter and you can get a certain amount without requiring a prescription, but you still need to present some form of identification that has been done in all US states by now. So I think that Kratom and or Tianeptin would qualify for something like that because then you need to interact with a pharmacist or a pharmacy technician to